LLY (Eli Lilly) מחיר לרווח עתידי

סמל מסחרי של Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY) is implementing ESG standards to reduce waste and ensure ethical treatment. A complex cold chain supply system guarantees the integrity of medications, while expansion in the diabetes segment requires a large-scale increase in capacity. The company's forward P/E dynamics reflect market earnings expectations, with the value stabilizing at 28.60, allowing for an objective assessment of the asset's investment potential.

מחיר לרווח עתידי: lilly.com (LLY) עבור 04.07.2022 - 16.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת lilly.com (LLY)

- מדדי הערכת שווי שוק של העסק:
אנליטיקה מסכמת של החברה:Lilly
פריט של המותג Eli Lilly and Company

The forward P/E determines the stock value relative to the projected net income for the following year. For Eli Lilly and Company (LLY), this ratio reflects market expectations regarding the success of its obesity and diabetes medications. By analyzing the company's forward P/E level, an investor assesses the degree of priced-in optimism. High values often offset risks associated with patent expirations and regulatory pressure. This metric allows for the identification of whether the asset is overbought or possesses a fundamental margin of safety.